메뉴 건너뛰기




Volumn 8, Issue 8, 2014, Pages

Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AMPHOTERICIN B; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 84930665828     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003053     Document Type: Article
Times cited : (55)

References (43)
  • 1
    • 85015555812 scopus 로고
    • Report on the consultative meeting on Leishmania/HIV co-infection. report no. WHO/LEISH/95.35, pp
    • World Health Organization. (1995) Report on the consultative meeting on Leishmania/HIV co-infection. report no. WHO/LEISH/95.35, pp. 1–14. Geneva: World Health Organization.
    • (1995)
  • 2
    • 0033093302 scopus 로고    scopus 로고
    • Epidemiology of visceral leishmaniasis in india
    • Bora D, (1999) Epidemiology of visceral leishmaniasis in india. Natl Med J India 12: 62–68.
    • (1999) Natl Med J India , vol.12 , pp. 62-68
    • Bora, D.1
  • 3
    • 84869811408 scopus 로고    scopus 로고
    • Estimate of HIV prevalence and number of people living with HIV in india 2008–2009
    • Pandey A, Sahu D, Bakkali T, Reddy D, Venkatesh S, et al. (2012) Estimate of HIV prevalence and number of people living with HIV in india 2008–2009. BMJ Open 2: e000926 doi:10.1136/bmjopen-2012-000926
    • (2012) BMJ Open , vol.2 , pp. e000926
    • Pandey, A.1    Sahu, D.2    Bakkali, T.3    Reddy, D.4    Venkatesh, S.5
  • 4
    • 85015555508 scopus 로고    scopus 로고
    • Government of India, Ministry of Health and Family Welfare. (2010) United Nations general assembly special session on HIV/AIDS country report: India.
    • (2010)
  • 5
    • 84873495696 scopus 로고    scopus 로고
    • T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: Is this paradigm still relevant?
    • Alexander J, Brombacher F, (2012) T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: Is this paradigm still relevant? Front Immunol 3: 80 doi:10.3389/fimmu.2012.00080
    • (2012) Front Immunol , vol.3 , pp. 80
    • Alexander, J.1    Brombacher, F.2
  • 6
    • 84861214279 scopus 로고    scopus 로고
    • Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection
    • Mock DJ, Hollenbaugh JA, Daddacha W, Overstreet MG, Lazarski CA, et al. (2012) Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection. PLoS Pathog 8: e1002635 doi:10.1371/journal.ppat.1002635
    • (2012) PLoS Pathog , vol.8 , pp. e1002635
    • Mock, D.J.1    Hollenbaugh, J.A.2    Daddacha, W.3    Overstreet, M.G.4    Lazarski, C.A.5
  • 7
    • 84871803448 scopus 로고    scopus 로고
    • Clinical aspects of visceral leishmaniasis in HIV infection
    • Jarvis JN, Lockwood DN, (2013) Clinical aspects of visceral leishmaniasis in HIV infection. Curr Opin Infect Dis 26: 1–9 doi:10.1097/QCO.0b013e32835c2198
    • (2013) Curr Opin Infect Dis , vol.26 , pp. 1-9
    • Jarvis, J.N.1    Lockwood, D.N.2
  • 8
    • 42349108596 scopus 로고    scopus 로고
    • The relationship between leishmaniasis and AIDS: The second 10 years
    • Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The relationship between leishmaniasis and AIDS: The second 10 years. Clin Microbiol Rev 21: 334–59 table of contents. doi:10.1128/CMR.00061-07
    • (2008) Clin Microbiol Rev , vol.21 , pp. 334-359
    • Alvar, J.1    Aparicio, P.2    Aseffa, A.3    Den Boer, M.4    Canavate, C.5
  • 10
    • 0037446441 scopus 로고    scopus 로고
    • Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: Is this combination increasing?
    • Thakur CP, Narayan S, Ranjan A, (2003) Kala-azar (visceral leishmaniasis) and HIV coinfection in Bihar, India: Is this combination increasing? J Acquir Immune Defic Syndr 32: 572–573.
    • (2003) J Acquir Immune Defic Syndr , vol.32 , pp. 572-573
    • Thakur, C.P.1    Narayan, S.2    Ranjan, A.3
  • 11
    • 33646894714 scopus 로고    scopus 로고
    • Leishmania-HIV co-infection: An emerging problem in India
    • Redhu NS, Dey A, Balooni V, Singh S, (2006) Leishmania-HIV co-infection: An emerging problem in India. AIDS 20: 1213–1215 doi:10.1097/01.aids.0000226971.42622.4e
    • (2006) AIDS , vol.20 , pp. 1213-1215
    • Redhu, N.S.1    Dey, A.2    Balooni, V.3    Singh, S.4
  • 12
    • 33745662611 scopus 로고    scopus 로고
    • Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics
    • Mathur P, Samantaray JC, Vajpayee M, Samanta P, (2006) Visceral leishmaniasis/human immunodeficiency virus co-infection in India: The focus of two epidemics. J Med Microbiol 55: 919–922 doi:10.1099/jmm.0.46574-0
    • (2006) J Med Microbiol , vol.55 , pp. 919-922
    • Mathur, P.1    Samantaray, J.C.2    Vajpayee, M.3    Samanta, P.4
  • 13
    • 0033653794 scopus 로고    scopus 로고
    • Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in india
    • Thakur CP, Sinha PK, Singh RK, Hassan SM, Narain S, (2000) Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in india. Trans R Soc Trop Med Hyg 94: 696–697.
    • (2000) Trans R Soc Trop Med Hyg , vol.94 , pp. 696-697
    • Thakur, C.P.1    Sinha, P.K.2    Singh, R.K.3    Hassan, S.M.4    Narain, S.5
  • 14
    • 84905017602 scopus 로고    scopus 로고
    • HIV and visceral leishmaniasis co-infection in Bihar, India: An under-recognised and under-diagnosed threat against elimination
    • Burza S, Mahajan R, Sanz MG, Sunyoto T, Kumar R, et al. (2014) HIV and visceral leishmaniasis co-infection in Bihar, India: An under-recognised and under-diagnosed threat against elimination. Clin Infect Dis E-pub ahead of print. doi:10.1093/cid/ciu333
    • (2014) Clin Infect Dis
    • Burza, S.1    Mahajan, R.2    Sanz, M.G.3    Sunyoto, T.4    Kumar, R.5
  • 15
    • 84878484762 scopus 로고    scopus 로고
    • Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: A systematic review with indirect comparison
    • Cota GF, de Sousa MR, Fereguetti TO, Rabello A, (2013) Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: A systematic review with indirect comparison. PLoS Negl Trop Dis 7: e2195 doi:10.1371/journal.pntd.0002195
    • (2013) PLoS Negl Trop Dis , vol.7 , pp. e2195
    • Cota, G.F.1    de Sousa, M.R.2    Fereguetti, T.O.3    Rabello, A.4
  • 17
    • 80052431603 scopus 로고    scopus 로고
    • Report of a meeting of the WHO expert committee on the control of leishmaniasis
    • WHO control of the leishmaniasis (2010) Report of a meeting of the WHO expert committee on the control of leishmaniasis, 22–26 March 2010. Geneva: WHO.
    • (2010)
  • 18
    • 84893752352 scopus 로고    scopus 로고
    • Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (ambisome) for visceral leishmaniasis in Bihar, India
    • Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, et al. (2014) Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (ambisome) for visceral leishmaniasis in Bihar, India. PLoS Negl Trop Dis 8: e2603 doi:10.1371/journal.pntd.0002603
    • (2014) PLoS Negl Trop Dis , vol.8 , pp. e2603
    • Burza, S.1    Sinha, P.K.2    Mahajan, R.3    Lima, M.A.4    Mitra, G.5
  • 19
    • 0036733664 scopus 로고    scopus 로고
    • Laboratory diagnosis of visceral leishmaniasis
    • Sundar S, Rai M, (2002) Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 9: 951–958.
    • (2002) Clin Diagn Lab Immunol , vol.9 , pp. 951-958
    • Sundar, S.1    Rai, M.2
  • 20
    • 85015548702 scopus 로고    scopus 로고
    • World Health Organization (2011) Field safety notice no. 1, 2011. Available: Http://www.who.int/diagnostics_laboratory/procurement/111201_productalert_for_product0027_mx012.pdf. Accessed 25 January 2014.
  • 21
    • 85015545883 scopus 로고    scopus 로고
    • World Health Organization (2010) Indicators for monitoring and evaluation of the kala-azar elimination programme. Available: http://www.who.int/tdr/publications/documents/kala_azar_indicators.pdf. Accessed 1 June 2014.
  • 22
    • 77955591768 scopus 로고    scopus 로고
    • Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India
    • Sinha PK, Roddy P, Palma PP, Kociejowski A, Lima MA, et al. (2010) Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India. Am J Trop Med Hyg 83: 357–364 doi:10.4269/ajtmh.2010.10-0156
    • (2010) Am J Trop Med Hyg , vol.83 , pp. 357-364
    • Sinha, P.K.1    Roddy, P.2    Palma, P.P.3    Kociejowski, A.4    Lima, M.A.5
  • 23
    • 80052502527 scopus 로고    scopus 로고
    • Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India
    • Sinha PK, van Griensven J, Pandey K, Kumar N, Verma N, et al. (2011) Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India. Clin Infect Dis 53: e91 doi:10.1093/cid/cir521
    • (2011) Clin Infect Dis , vol.53 , pp. e91
    • Sinha, P.K.1    van Griensven, J.2    Pandey, K.3    Kumar, N.4    Verma, N.5
  • 24
    • 20344370565 scopus 로고    scopus 로고
    • Multiple imputation of missing values
    • Royston P, (2004) Multiple imputation of missing values. Stata Journal 4: 227–241.
    • (2004) Stata Journal , vol.4 , pp. 227-241
    • Royston, P.1
  • 25
    • 67651112075 scopus 로고    scopus 로고
    • Competing risk regression models for epidemiologic data
    • Lau B, Cole SR, Gange SJ, (2009) Competing risk regression models for epidemiologic data. Am J Epidemiol 170: 244–256 doi:10.1093/aje/kwp107
    • (2009) Am J Epidemiol , vol.170 , pp. 244-256
    • Lau, B.1    Cole, S.R.2    Gange, S.J.3
  • 26
    • 0030915453 scopus 로고    scopus 로고
    • Non-parametric inference for cumulative incidence functions in competing risks studies
    • Lin DY, (1997) Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 16: 901–910.
    • (1997) Stat Med , vol.16 , pp. 901-910
    • Lin, D.Y.1
  • 27
    • 79959822382 scopus 로고    scopus 로고
    • Predictors of visceral leishmaniasis relapse in HIV-infected patients: A systematic review
    • Cota GF, de Sousa MR, Rabello A, (2011) Predictors of visceral leishmaniasis relapse in HIV-infected patients: A systematic review. PLoS Negl Trop Dis 5: e1153 doi:10.1371/journal.pntd.0001153
    • (2011) PLoS Negl Trop Dis , vol.5 , pp. e1153
    • Cota, G.F.1    de Sousa, M.R.2    Rabello, A.3
  • 28
    • 43949118839 scopus 로고    scopus 로고
    • Concordant HIV infection and visceral leishmaniasis in Ethiopia: The influence of antiretroviral treatment and other factors on outcome
    • ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN, (2008) Concordant HIV infection and visceral leishmaniasis in Ethiopia: The influence of antiretroviral treatment and other factors on outcome. Clin Infect Dis 46: 1702–1709 doi:10.1086/587899
    • (2008) Clin Infect Dis , vol.46 , pp. 1702-1709
    • ter Horst, R.1    Collin, S.M.2    Ritmeijer, K.3    Bogale, A.4    Davidson, R.N.5
  • 29
    • 81855160861 scopus 로고    scopus 로고
    • Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an ethiopian population with high HIV prevalence
    • Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, et al. (2011) Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an ethiopian population with high HIV prevalence. Clin Infect Dis 53: e152–8 doi:10.1093/cid/cir674
    • (2011) Clin Infect Dis , vol.53 , pp. e152-e158
    • Ritmeijer, K.1    ter Horst, R.2    Chane, S.3    Aderie, E.M.4    Piening, T.5
  • 30
    • 84893791064 scopus 로고    scopus 로고
    • Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (ambisome) in Bihar, India
    • Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, et al. (2014) Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (ambisome) in Bihar, India. PLoS Negl Trop Dis 8: e2536 doi:10.1371/journal.pntd.0002536
    • (2014) PLoS Negl Trop Dis , vol.8 , pp. e2536
    • Burza, S.1    Sinha, P.K.2    Mahajan, R.3    Lima, M.A.4    Mitra, G.5
  • 31
    • 84886933515 scopus 로고    scopus 로고
    • One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India
    • Burza S, Nabi E, Mahajan R, Mitra G, Lima MA, (2013) One-year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India. Clin Infect Dis 57: 1363–1364 doi:10.1093/cid/cit508
    • (2013) Clin Infect Dis , vol.57 , pp. 1363-1364
    • Burza, S.1    Nabi, E.2    Mahajan, R.3    Mitra, G.4    Lima, M.A.5
  • 32
    • 84877283879 scopus 로고    scopus 로고
    • Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
    • Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, et al. (2013) Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 56: 1530–1538 doi:10.1093/cid/cit102
    • (2013) Clin Infect Dis , vol.56 , pp. 1530-1538
    • Rijal, S.1    Ostyn, B.2    Uranw, S.3    Rai, K.4    Bhattarai, N.R.5
  • 33
    • 85015544129 scopus 로고    scopus 로고
    • Antiretroviral therapy guidelines for HIV-infected adults and adolescents, including post-exposure prophylaxis
    • National AIDS Control Organization (2007) Antiretroviral therapy guidelines for HIV-infected adults and adolescents, including post-exposure prophylaxis, May 2007, 125 pp.
    • (2007) May , vol.2007 , pp. 125
  • 34
    • 84879146007 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India
    • Rai S, Mahapatra B, Sircar S, Raj PY, Venkatesh S, et al. (2013) Adherence to antiretroviral therapy and its effect on survival of HIV-infected individuals in Jharkhand, India. PLoS One 8: e66860 doi:10.1371/journal.pone.0066860
    • (2013) PLoS One , vol.8 , pp. e66860
    • Rai, S.1    Mahapatra, B.2    Sircar, S.3    Raj, P.Y.4    Venkatesh, S.5
  • 35
    • 85015543336 scopus 로고    scopus 로고
    • National AIDS Control Organization And Central TB Division (2010) Ministry of health & family welfare government of India, New Delhi. TB/HIV module for ART centre staff. Available: http://www.tbcindia.nic.in/pdfs/TB-HIV%20Module%20for%20ART%20Centre%20Staff.pdf. Accessed: 1 May 2014.
  • 36
    • 85015546064 scopus 로고    scopus 로고
    • National AIDS Control organisation Ministry of Health and Family Welfare Government of India (2012) Operational guidelines for ART services 2012. Available: Http://www.naco.gov.in/upload/Publication/Treatment%20Care%20and%20support/Operational%20guidelines%20for%20ART%20services.pdf Accessed 26 January 2014.
  • 38
    • 84862944418 scopus 로고    scopus 로고
    • Mechanism of amphotericin B resistance in clinical isolates of leishmania donovani
    • Purkait B, Kumar A, Nandi N, Sardar AH, Das S, et al. (2012) Mechanism of amphotericin B resistance in clinical isolates of leishmania donovani. Antimicrob Agents Chemother 56: 1031–1041 doi:10.1128/AAC.00030-11
    • (2012) Antimicrob Agents Chemother , vol.56 , pp. 1031-1041
    • Purkait, B.1    Kumar, A.2    Nandi, N.3    Sardar, A.H.4    Das, S.5
  • 39
    • 0031903651 scopus 로고    scopus 로고
    • Leishmania infantum: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis
    • Durand R, Paul M, Pratlong F, Rivollet D, Dubreuil-Lemaire ML, et al. (1998) Leishmania infantum: Lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis. Antimicrob Agents Chemother 42: 2141–2143.
    • (1998) Antimicrob Agents Chemother , vol.42 , pp. 2141-2143
    • Durand, R.1    Paul, M.2    Pratlong, F.3    Rivollet, D.4    Dubreuil-Lemaire, M.L.5
  • 40
    • 58749113633 scopus 로고    scopus 로고
    • Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and leishmania infantum
    • Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, et al. (2009) Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and leishmania infantum. Clin Infect Dis 48: e16–22 doi:10.1086/595710
    • (2009) Clin Infect Dis , vol.48 , pp. e16-22
    • Lachaud, L.1    Bourgeois, N.2    Plourde, M.3    Leprohon, P.4    Bastien, P.5
  • 41
    • 84904369974 scopus 로고    scopus 로고
    • Multiple relapses of viceral leishmaniasis in a patient with HIV in India: A treatment challenge. International journal of infectious diseases
    • Patole S, Burza S, Varghese G, (2014) Multiple relapses of viceral leishmaniasis in a patient with HIV in India: A treatment challenge. International journal of infectious diseases. Int J Infect Dis E-pub ahead of print. doi:10.1016/j.ijid.2014.02.015
    • (2014) Int J Infect Dis
    • Patole, S.1    Burza, S.2    Varghese, G.3
  • 42
    • 80055078978 scopus 로고    scopus 로고
    • Incidence of symptomatic and asymptomatic leishmania donovani infections in high-endemic foci in India and Nepal: A prospective study
    • Ostyn B, Gidwani K, Khanal B, Picado A, Chappuis F, et al. (2011) Incidence of symptomatic and asymptomatic leishmania donovani infections in high-endemic foci in India and Nepal: A prospective study. PLoS Negl Trop Dis 5: e1284 doi:10.1371/journal.pntd.0001284
    • (2011) PLoS Negl Trop Dis , vol.5 , pp. e1284
    • Ostyn, B.1    Gidwani, K.2    Khanal, B.3    Picado, A.4    Chappuis, F.5
  • 43
    • 85015552851 scopus 로고    scopus 로고
    • National vector borne disease control programme (2008) Directorate general of health services, ministry of health and family welfare. project implementation plan: National vector borne disease control support project under world bank on malaria control & kala-azar elimination (2008–2013). Available: Http://nvbdcp.gov.in/Doc/PIP.pdf. Accessed 20 January 2014.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.